8
Oct
2024

Coriolis

Exhibitor at CPHI Milan 2024 stand 7F74, Contract Manufacturing and Services
About Us

Coriolis Pharma is a globally operating contract research organization (CRO) and a leader in formulation research and development of (bio)pharmaceutical drugs, including cell and gene therapy products and vaccines. 

Founded in 2008, Coriolis is the expert for early and late-stage biopharmaceutical development of liquid and lyophilized drug products, including lyophilization process development and analytical method development under R&D and GMP.  Non-GMP manufacturing services for a wide range of products complete the service portfolio. 

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • DE
  • 2022
    On CPHI since
  • 1
    Certificates
  • 100 - 249
    Employees
Company types
Contract Research Organisation (CRO)
Primary activities
Analytical Services
Biopharmaceutical
Contract Research Organisation
Laboratory Services
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 7F74, Contract Manufacturing and Services

Products Featured at CPHI Milan 2024

  • Formulation Development

    Product Formulation Development

    Coriolis develops formulations for liquid, frozen and lyophilized drug products. This includes: • preformulation screening • preclinical formulation development • transfer of formulations to external CMO • formulation development for clinical phas I and II • formulations for late clinical development (...
  • Analytical method development and services

    Product Analytical method development and services

    Our analytical portfolio comprises 100+ different techniques – all performed by Coriolis’ experts in-house. Our offering includes:
    • Aggregate analytics • Particle characterization • Particle identification • Surfactant characterization • Higher order structure analysis • Funcional assays • Chemi...
  • Lyophilization Process Development

    Product Lyophilization Process Development

    We operate freeze-dryers from lab to production scale and develop processes for many different biopharmaceutical drug products, including highly concentrated protein formulations, organic solvent containing formulations and drug substances that fall under biosafety level S2 (such as live virus vaccines, vi...
  • In-use stability studies

    Product In-use stability studies

    We assess a variety of factors, including the effect of dilution and the dilution medium, potential adsorption to surface materials, shear forces during application, variations in extractable volume and reconstitution, formation or introduction of aggregates and (sub)visible particles, and more. While indi...
  • Forced Degradation Studies / Stress Testing

    Product Forced Degradation Studies / Stress Testing

    Our service for forced degradation studies includes:
    • Freeze-thaw • Temperature excursion • Pumping • Stirring • Shaking/agitation • Drop • Light exposure • Chemical spiking • pH shift • Oxidation